0001437749-23-030250.txt : 20231103
0001437749-23-030250.hdr.sgml : 20231103
20231103174133
ACCESSION NUMBER: 0001437749-23-030250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231023
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danahy Kevin Patrick
CENTRAL INDEX KEY: 0001913245
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 231377515
MAIL ADDRESS:
STREET 1: 50 TEABERRY LANE
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-10-23
0001625101
Pulse Biosciences, Inc.
PLSE
0001913245
Danahy Kevin Patrick
C/O PULSE BIOSCIENCES, INC.
3957 POINT EDEN WAY
HAYWARD
CA
94545
1
Chief Executive Officer
0
Stock Option (right to buy)
3.96
2023-10-23
4
A
0
130000
0
A
2033-10-23
Common Stock
130000
130000
D
Stock Option (right to buy)
3.96
2023-11-01
4
J
0
130000
0
D
2033-10-23
Common Stock
130000
0
D
Stock Option (right to buy)
4.38
2023-11-01
4
A
0
460000
0
A
2033-11-01
Common Stock
460000
460000
D
The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date.
Reporting Person was erroneously granted an option to acquire 130,000 shares on October 23, 2023, which option was cancelled by mutual agreement on November 1, 2023.
100% vesting upon the earlier of (i) the six (6) year anniversary of the grant date, and (ii) the 1-year anniversary of a Company change of control.
/s/ Kenneth B. Stratton, as Attorney-in-Fact
2023-11-03